Delivery Order SPE2DB22D9244-SPE2DB25FZS44
- Not listed
- This delivery order, awarded on July 23, 2025, by the Defense Logistics Agency's Medical Supply Chain to DMS Pharmaceutical Group Inc., covers the supply of EXPAREL 266 mg/20 mL vials with a firm fixed price ceiling of $25,106.30 and an ultimate completion date of August 13, 2025. EXPAREL is a liposomal bupivacaine formulation used for surgical anesthesia and post-operative pain management. The award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on July 24, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, valued at $50,212.60, is set to be completed by August 14, 2025, with performance taking place at the company's Park Ridge location. The award carries no set-aside designation, reflecting the contractor's competitive...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $15,063.78 by the Defense Logistics Agency on July 25, 2025, for the supply of EXPAREL 266 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and carries no set-aside designation. This award represents a single delivery order issued under DMS Pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on July 21, 2025. The delivery order is for EXPAREL 266 mg/20 mL vials, a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management. The contract carries no set-aside designation, and DMS Pharmaceutical Group is competing as a small business...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,510.63 for EXPAREL 1.3% 20ML (10 units) on July 22, 2025. The award was made by the Defense Logistics Agency's Medical Supply Chain on a firm fixed-price basis with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999...
- The Defense Logistics Agency Troop Support Medical has awarded DMS Pharmaceutical Group Inc. a firm fixed price delivery order valued at one thousand one hundred thirty dollars for EXPAREL 133 MG/10 ML vials. DMS Pharmaceutical Group will provide ten milliliter vials of EXPAREL, an extended-release bupivacaine liposome injectable suspension, to fulfill requirements under the order. Performance will be completed by December 4, 2023 at the place of performance in Park Ridge, Illinois. As a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,510.63 by the Defense Logistics Agency on July 24, 2025, for the supply of Exparel 266 mg/20 ml vials. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA. The award carries no set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a $14,923.32 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of the pharmaceutical product EXPAREL (bupivacaine liposome injectable suspension) 266 mg/20 mL vial. This delivery order is issued against DMS Pharmaceutical Group's larger indefinite delivery vehicle (IDV) contract SPE2DB24FSW76 with DLA, valued up to $4,999,999...
- The U.S. Defense Logistics Agency awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of EXPAREL 266 MG/20 ML VIAL 20ML pharmaceutical products. The contract has a potential value of $29,846.64 and a completion date of March 12, 2024. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of branded and generic drugs to government agencies, primarily the...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract for EXPAREL 266 MG/20 ML VIAL 20ML to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a potential value of $29,846.64 and a completion date of February 16, 2024. DMS Pharmaceutical Group Inc. holds an indefinite delivery contract, contract 4600082013 under the SPE2DB program, with the Defense Logistics Agency valued at up to...
- SPE2DB22D9244Indefinite Delivery Contract
- SPE2DB22D9244-SPE2DB25FZS44Delivery Order
The Defense Logistics Agency awarded a $25.1K delivery order to DMS Pharmaceutical Group Inc. on July 21, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine product used for infiltration and nerve block anesthesia in surgical settings. This delivery order is issued without a set-aside designation and carries an ultimate completion date of August 11, 2025, under a firm fixed-price arrangement. The work will be performed in Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters. DMS Pharmaceutical Group, a woman-owned small business and pharmaceutical wholesaler, secured this delivery order through its existing single-award Indefinite Delivery Contract with DLA under the SPE2DB program, valued at $499.9M through November 2026. This IDC framework enables DLA to issue firm fixed-price delivery orders for pharmaceutical products supporting military healthcare facilities worldwide. The contractor specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to federal agencies and has maintained an extensive portfolio of pharmaceutical supply contracts with the Defense Logistics Agency since its SAM.gov registration in 2001.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.1k | 7/21/25 |